1-11 of 11
Eric R. Siegel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3

Free
Sangini S. Sheth, Ji Eun Oh, Stefania Bellone, Eric R. Siegel, Natalia Buza, Akiko Iwasaki, Alessandro D. Santin
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4104.
https://doi.org/10.1158/1538-7445.AM2024-4104
Published: 22 March 2024
View article titled, Abstract 4104: Randomized phase II trial of imiquimod with or without 9vHPV vs observation in patients with CIN 2 and 3
Journal Articles

Abstract 700: Induction of cancer-specific T-cell responses in patients immunized with P10s-PADRE vaccine

Free
John J. Lee, Bernice C. Nounamo, Fariba Jousheghany, Issam Makhoul, Eric R. Siegel, Thomas Kieber-Emmons, Behjatolah Monzavi-Karbassi
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 700.
https://doi.org/10.1158/1538-7445.AM2023-700
Published: 04 April 2023
View article titled, Abstract 700: Induction of cancer-specific T-cell responses in patients immunized with P10s-PADRE vaccine
Journal Articles

Abstract 3529: T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis

Free
Samir V. Jenkins, Michael S. Robeson, Eric R. Siegel, Charles M. Quick, Robert J. Griffin, Martin J. Cannon, Kieng B. Vang, Ruud P. Dings
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3529.
https://doi.org/10.1158/1538-7445.AM2022-3529
Published: 15 June 2022
View article titled, Abstract 3529: T-cell trafficking and extravasation is suppressed in distal tumors during gastrointestinal tract dysbiosis
Journal Articles

Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking

Free
Samir V. Jenkins, Michael S. Robeson, II, Robert J. Griffin, Charles M. Quick, Eric R. Siegel, Martin J. Cannon, Kieng B. Vang, Ruud P.M. Dings
Journal: Cancer Research
Cancer Res (2019) 79 (23): 5999–6009.
https://doi.org/10.1158/0008-5472.CAN-18-4108
Published: 02 December 2019
View article titled, Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking
Open the PDF for Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking in another window
Includes: Supplementary data
Journal Articles

Abstract 747: Glutamine, glutaminase and γ-glutamyl-transferase activities are essential for lung tumorigenesis

Free
Daniel R. Sappington, Eric R. Siegel, Rosalind B. Penney, Gunnar Boysen
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 747.
https://doi.org/10.1158/1538-7445.AM2015-747
Published: 01 August 2015
View article titled, Abstract 747: Glutamine, glutaminase and γ-glutamyl-transferase activities are essential for lung tumorigenesis
Journal Articles

Abstract CT202: A Phase I study of a first-in-man carbohydrate mimetic-peptide vaccine in Stage IV breast cancer subjects

Free
Laura Hutchins, Issam Makhoul, Peter D. Emanuel, Eric R. Siegel, Fariba Jousheghany, Behjatolah Monzavi-Karbassi, Thomas Kieber-Emmons
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): CT202.
https://doi.org/10.1158/1538-7445.AM2014-CT202
Published: 01 October 2014
View article titled, Abstract CT202: A Phase I study of a first-in-man carbohydrate mimetic-peptide vaccine in Stage IV breast cancer subjects
Journal Articles

Abstract 2825: Germline genetic variants in ANGPT1 & 2 and FGF2 are associated with pathologic complete response to bevacizumab in breast cancer patients

Free
Issam Makhoul, Robert Griffin, Stephen Erickson, Ishwori Dhakal, Venay R. Raj, Dorothy A. Graves, Jeannette Y. Lee, Mohammed S. Orloff, Eric R. Siegel, Susan A. Kadlubar
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 2825.
https://doi.org/10.1158/1538-7445.AM2014-2825
Published: 01 October 2014
View article titled, Abstract 2825: Germline genetic variants in ANGPT1 & 2 and FGF2 are associated with pathologic complete response to bevacizumab in breast cancer patients
Journal Articles

Abstract 3236: Molecular characterization of lung tumors based on metabolomic profiling.

Free
Daniel R. Sappington, Scott Helms, Ishwori B. Dhakal, Eric R. Siegel, Thaddeus Bartter, Gunnar Boysen
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3236.
https://doi.org/10.1158/1538-7445.AM2013-3236
Published: 15 April 2013
View article titled, Abstract 3236: Molecular characterization of lung tumors based on metabolomic profiling.
Journal Articles

Claudin-3 and Claudin-4: New targets for the treatment of chemotherapy resistant uterine serous papillary carcinoma using clostridium perfringens enterotoxin

Free
Alessandro D. Santin, Stefania Bellone, Michela Palmieri, Moira Marizzoni, Alessandro Zanolini, Fabrizio Comper, Eric R. Siegel, Maria Thomas, Leah Leah Hennings, Juan J. Roman, Alexander Burnett, Sergio Pecorelli
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 1084.
Published: 15 April 2006
View article titled, Claudin-3 and Claudin-4: New targets for the treatment of chemotherapy resistant uterine serous papillary carcinoma using clostridium perfringens enterotoxin
Journal Articles

Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin

Free
Alessandro D. Santin, Stefania Cané, Stefania Bellone, Michela Palmieri, Eric R. Siegel, Maria Thomas, Juan J. Roman, Alexander Burnett, Martin J. Cannon, Sergio Pecorelli
Journal: Cancer Research
Cancer Res (2005) 65 (10): 4334–4342.
https://doi.org/10.1158/0008-5472.CAN-04-3472
Published: 16 May 2005
View article titled, Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin
Open the PDF for Treatment of Chemotherapy-Resistant Human Ovarian Cancer Xenografts in C.B-17/SCID Mice by Intraperitoneal Administration of Clostridium perfringens Enterotoxin in another window
Journal Articles

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of clostridium perfringens enterotoxin (CPE)

Free
Alessandro D. Santin, Stefania Bellone, Michela Palmieri, Stefania Cane, Eric R. Siegel, Maria Thomas, Juan J. Roman, Alexander Burnett, Martin J. Cannon, Sergio Pecorelli
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1188–1189.
Published: 01 May 2005
View article titled, Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of clostridium perfringens enterotoxin (CPE)